Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

GMED 22.61 +0.21 (0.94%)
price chart
Globus Medical: A Pattern Of Earnings Beats
Globus Medical is a medical devices company focused on the design and development of products for patients with spine disorders.
Globus Medical Incorporated (NYSE:GMED) Shorts Decreased by 0.65% After ...  fdanewsalert.com
Gofen & Glossberg LLC IL Increases Stake in Globus Medical Inc (GMED)  Intercooler Financial
Globus Medical Announces Litigation Settlement Agreement
AUDUBON, Pa., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced DePuy Synthes Products, Inc., DePuy Synthes Sales, Inc. and Globus Medical, Inc. have settled ...
Weekly Analysts' Ratings Changes for Globus Medical (GMED)  Corvus Business Newswire
Globus Medical Inc (GMED) Rating Lowered to Underperform at Bank of America
Globus Medical logo Globus Medical Inc (NASDAQ:GMED) was downgraded by equities researchers at Bank of America from a “buy” rating to an “underperform” rating in a report released on Friday, The Fly reports.
Price Target Update On Globus Medical, Inc. (NYSE:GMED)  Risers & Fallers
Capital Impact Advisors Continues to Hold Position in Globus Medical Inc (GMED)
Globus Medical logo Capital Impact Advisors continued to hold its stake in Globus Medical Inc (NASDAQ:GMED) during the fourth quarter, according to its most recent Form 13F filing with the SEC.
Analysts Set Globus Medical Inc (NASDAQ:GMED) Price Target at $29.00  Zolmax
Analyst Price Target on Globus Medical, Inc.  Market Briefing
Shareholder Class Action Filed Against Globus Medical, Inc. - GMED
RADNOR, Pa., Oct. 8, 2015 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against Globus Medical, Inc. (NYSE: GMED) ("Globus Medical" or the "Company") on behalf of ...
Globus Medical Inc (GMED) Raised to Buy at Zacks Investment Research
Globus Medical Inc logo Zacks Investment Research upgraded shares of Globus Medical Inc (NASDAQ:GMED) from a hold rating to a buy rating in a report published on Saturday, Market Beat.
BofA Merrill Decreases Globus Medical (NYSE:GMED) to "Underperform" ...  OctaFinance.com
Globus Medical Reports Preliminary Fourth Quarter and Full Year Record Sales ...
AUDUBON, Pa., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2015, ...
Globus Medical Inc (GMED) Updates FY16 Earnings Guidance  EMQ
Globus Medical to Participate in 34th Annual J.P. Morgan Healthcare Conference  OrthoSpineNews
Stock Alert: Globus Medical, Inc. (NYSE:GMED)
Thomson Reuters, a reputed brokerage firm, has set a 52-week price target of $31.4000 on Globus Medical, Inc. (NYSE:GMED) stock after conducting a poll of famous analysts.
Robbins Arroyo LLP: Globus Medical, Inc. (GMED) Misled Shareholders According ...
The complaint alleges that officers and directors of Globus Medical, Inc. (NYSE: GMED) violated the Securities Exchange Act of 1934 between February 26, 2014 and August 5, 2014, by making materially false and misleading statements about Globus ...
Globus Medical Announces the Acquisition of Branch Medical Group, Inc.
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has entered into an agreement to acquire Branch Medical Group, Inc. (“BMG”), a third party manufacturer of ...
Two Montco companies agree to $52.9M deal  Philadelphia Business Journal (blog)
Globus Medical's (GMED) CEO David Paul on Q4 2014 Results - Earnings ...  Seeking Alpha (registration)